Medicare will negotiate prices for Part B injectable drugs for the first time, aiming to lower costs for millions of patients ...

A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with this condition worldwide, daily treatment has meant taking levodopa and ...

President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...

The phase 2 trial of CT-388, a once-weekly subcutaneous injection acquired as part of its $2.7 billion takeover of Carmot ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

LONDON — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. In a statement ...

As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.

Researchers have found that a long-acting injection, given just twice a year alongside standard drugs. Blood pressure is one of the most common health problems worldwide, yet it remains difficult to ...

In two ancillary studies of two multi-center international clinical trials led by the University of Southern California (USC) Eye Institute, the injectable drug ocriplasmin appears to improve vision ...

New Medicare data shows which drugs cost the most, how many seniors take them, and why both volume and price matter for Part ...